HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jason J Luke Selected Research
Jason J Luke Research Topics
Disease
97
Neoplasms (Cancer)
04/2024 - 04/2012
78
Melanoma (Melanoma, Malignant)
04/2024 - 01/2012
12
Neoplasm Metastasis (Metastasis)
03/2024 - 10/2013
11
Uveal melanoma
10/2023 - 10/2013
6
Disease Progression
01/2023 - 01/2016
5
Bites and Stings (Sting)
01/2023 - 01/2019
4
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2024 - 02/2015
4
Sarcoma (Soft Tissue Sarcoma)
01/2021 - 04/2012
4
Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 02/2015
3
Fatigue
03/2024 - 11/2015
3
Fever (Fevers)
01/2022 - 01/2014
3
Lung Neoplasms (Lung Cancer)
01/2018 - 03/2014
2
Brain Neoplasms (Brain Tumor)
10/2023 - 10/2022
2
Hypoxia (Hypoxemia)
01/2023 - 01/2022
2
Pneumonia (Pneumonitis)
11/2022 - 01/2022
2
Autoimmune Hepatitis
11/2022 - 01/2014
2
Hypertension (High Blood Pressure)
11/2022 - 11/2015
2
Diarrhea
01/2022 - 01/2017
2
Inflammation (Inflammations)
01/2022 - 05/2021
2
Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 01/2020
2
Ascites
01/2020 - 01/2018
2
Urinary Bladder Neoplasms (Bladder Cancer)
01/2019 - 01/2018
2
Testicular Neoplasms (Testicular Cancer)
11/2016 - 06/2013
1
Prostatic Neoplasms (Prostate Cancer)
04/2024
1
Colorectal Neoplasms (Colorectal Cancer)
03/2024
1
Squamous Cell Carcinoma of Head and Neck
03/2024
1
Dermatitis
03/2024
1
Skin Neoplasms (Skin Cancer)
01/2024
Drug/Important Bio-Agent (IBA)
36
Immune Checkpoint Inhibitors
IBA
04/2024 - 01/2014
28
pembrolizumab
IBA
03/2024 - 02/2015
27
Ipilimumab
IBA
01/2024 - 04/2013
14
Biomarkers (Surrogate Marker)
IBA
04/2024 - 11/2016
14
Nivolumab
IBA
03/2024 - 02/2015
10
Interferons
IBA
02/2024 - 01/2018
8
Proteins (Proteins, Gene)
FDA Link
01/2023 - 10/2013
7
Cytokines
IBA
01/2023 - 01/2018
7
Antibodies
IBA
12/2020 - 01/2014
7
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2020 - 06/2013
5
trametinib
IBA
01/2023 - 06/2013
5
Antigens
IBA
10/2022 - 06/2013
5
DNA (Deoxyribonucleic Acid)
IBA
05/2021 - 03/2014
5
Catenins
IBA
10/2020 - 05/2019
5
Vemurafenib
IBA
11/2019 - 01/2012
4
Monoclonal Antibodies
IBA
03/2024 - 01/2014
4
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2024 - 10/2022
4
Programmed Cell Death 1 Receptor
IBA
10/2023 - 01/2019
4
Enzymes
IBA
01/2023 - 01/2015
4
Chemokines
IBA
01/2023 - 01/2019
4
epacadostat
IBA
01/2023 - 11/2018
4
Adrenal Cortex Hormones (Corticosteroids)
IBA
10/2022 - 02/2015
4
dabrafenib
IBA
01/2022 - 06/2013
3
Adenosine (Adenocard)
FDA Link
Generic
01/2022 - 01/2020
3
Gemcitabine
FDA Link
01/2022 - 11/2015
3
Vaccines
IBA
12/2020 - 01/2016
3
Ligands
IBA
11/2019 - 11/2016
2
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
04/2024 - 01/2019
2
Protein Isoforms (Isoforms)
IBA
04/2024 - 01/2018
2
urelumab
IBA
03/2024 - 10/2021
2
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
02/2024 - 09/2019
2
Interleukin-8 (Interleukin 8)
IBA
02/2024 - 01/2023
2
B7-H1 Antigen
IBA
10/2023 - 01/2019
2
RNA (Ribonucleic Acid)
IBA
08/2023 - 01/2022
2
Blood Proteins (Serum Proteins)
IBA
01/2023 - 01/2022
2
atezolizumab
IBA
01/2023 - 01/2019
2
Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)
IBA
01/2023 - 11/2018
2
Indicators and Reagents (Reagents)
IBA
11/2022 - 01/2017
2
tebentafusp
IBA
11/2022 - 10/2022
2
Mitogen-Activated Protein Kinases
IBA
10/2022 - 01/2014
2
Toll-Like Receptor 9
IBA
12/2021 - 01/2020
2
Interferon Type I
IBA
05/2021 - 01/2019
2
Immunoconjugates (Immunoconjugate)
IBA
01/2021 - 01/2019
2
Interleukin-2 (IL2)
IBA
01/2021 - 04/2013
2
Transcription Factors (Transcription Factor)
IBA
10/2020 - 01/2018
2
Hormones (Hormone)
IBA
10/2020 - 02/2015
2
Dacarbazine (DIC)
FDA Link
Generic
01/2020 - 04/2013
2
Valine (L-Valine)
FDA Link
01/2019 - 01/2012
2
Codon (Codons)
IBA
01/2019 - 01/2012
2
Blocking Antibodies
IBA
01/2018 - 01/2016
2
Proto-Oncogene Proteins B-raf
IBA
01/2018 - 08/2014
2
Docetaxel (Taxotere)
FDA Link
03/2016 - 11/2015
1
Midazolam (Versed)
FDA Link
Generic
04/2024
1
Cytochrome P-450 CYP3A
IBA
04/2024
1
capivasertib
IBA
04/2024
1
Cetuximab (Erbitux)
FDA Link
03/2024
1
C-Reactive Protein
IBA
02/2024
1
Tacrolimus (Prograf)
FDA Link
Generic
01/2024
1
prednylidene (Pred)
IBA
01/2024
1
Prednisone (Sone)
FDA Link
Generic
01/2024
1
Messenger RNA (mRNA)
IBA
01/2024
1
margetuximab
IBA
11/2023
1
HLA-A Antigens (HLA-A)
IBA
10/2023
1
p38 Mitogen-Activated Protein Kinases
IBA
08/2023
1
Nucleotides
IBA
01/2023
Therapy/Procedure
62
Therapeutics
04/2024 - 01/2012
56
Immunotherapy
04/2024 - 05/2013
9
Drug Therapy (Chemotherapy)
10/2023 - 04/2012
6
Radiotherapy
11/2023 - 01/2018
2
Injections
10/2023 - 01/2023
2
Precision Medicine
01/2023 - 01/2021
1
Oncolytic Virotherapy
10/2023